Last reviewed · How we verify
Uncomplicated urogenital gonorrhea
Approved treatments
- Blujepa · Glaxosmithkline
Blujepa works by inhibiting bacterial DNA polymerase, preventing the replication of bacterial DNA and ultimately leading to bacterial cell death.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Uncomplicated urogenital gonorrhea patent landscape — cliff calendar, originator estates, attackable patents
- Uncomplicated urogenital gonorrhea treatment landscape brief
- Uncomplicated urogenital gonorrhea treatment updates RSS
Frequently asked questions about Uncomplicated urogenital gonorrhea
What drugs treat Uncomplicated urogenital gonorrhea?
Tracked treatments include Blujepa.
What is the treatment for Uncomplicated urogenital gonorrhea?
Standard treatment for Uncomplicated urogenital gonorrhea includes Blujepa. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Uncomplicated urogenital gonorrhea patent cliff · Uncomplicated urogenital gonorrhea CI report
- Treatment: Blujepa · Glaxosmithkline
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing